|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
CA2264852C
(en)
*
|
1996-09-30 |
2005-11-01 |
Alza Corporation |
Use of methylphenidate or a pharmaceutically acceptable salt thereof
|
|
EP1690531A3
(en)
*
|
1996-09-30 |
2010-01-20 |
Alza Corporation |
Dosage form and method for administering drug
|
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
PT946151E
(pt)
*
|
1996-11-25 |
2006-07-31 |
Alza Corp |
Forma de dosagem de dose crescente
|
|
US6962997B1
(en)
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
|
AU2004200938B2
(en)
*
|
1998-06-03 |
2006-09-14 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
ATE277594T1
(de)
*
|
1998-06-03 |
2004-10-15 |
Alza Corp |
Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
|
|
KR100890537B1
(ko)
*
|
1998-06-03 |
2009-03-27 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
|
KR100827254B1
(ko)
*
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
|
AU2012232984B2
(en)
*
|
1998-06-03 |
2015-10-29 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
MXPA01004381A
(es)
|
1998-11-02 |
2005-09-08 |
Elan Corp Plc |
Composicion de multiparticulado de liberacion modificada.
|
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
|
US6673367B1
(en)
*
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
|
WO2000059479A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
|
|
IL150657A0
(en)
*
|
2000-01-20 |
2003-02-12 |
Delsys Pharmaceutical Corp |
Multi-step drug dosage forms
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
NZ570198A
(en)
*
|
2002-07-29 |
2010-01-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of paliperidone or risperidone
|
|
AR041744A1
(es)
*
|
2002-10-31 |
2005-05-26 |
Alza Corp |
Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
|
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
NZ546183A
(en)
*
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
|
CA2540308C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
WO2015001488A1
(en)
|
2013-07-01 |
2015-01-08 |
Ranbaxy Laboratories Limited |
Extended-release tablets of paliperidone and processes of preparation thereof
|
|
CA2936740C
(en)
|
2014-10-31 |
2017-10-10 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
US20180360817A1
(en)
*
|
2015-12-31 |
2018-12-20 |
Cadila Healthcare Limited |
Extended release osmotic dosage form comprising high methylphenidate hydrochloride load
|
|
EP3501504A1
(en)
|
2017-12-22 |
2019-06-26 |
Pharmacia Polonica sp. z o.o. |
Modified release tablet of paliperidone and a process for the preparation thereof
|
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|